Immix Biopharma Inc Files For Shelf Of Up To 5.2M Shares Of Common Stock By Selling Stockholder
Portfolio Pulse from Benzinga Newsdesk
Immix Biopharma Inc has filed for a shelf of up to 5.2 million shares of common stock by a selling stockholder, according to a SEC filing.
September 25, 2023 | 8:23 pm
News sentiment analysis
Sort by:
Descending
NEGATIVE IMPACT
Immix Biopharma Inc's filing for a shelf of up to 5.2 million shares could potentially dilute the value of existing shares, impacting the stock price.
The filing for a shelf of up to 5.2 million shares by Immix Biopharma Inc could lead to dilution of the value of existing shares if the new shares are issued. This could potentially lead to a decrease in the stock price in the short term.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100